3 ·Filed Aug 4, 2026
Form 3 — initial insider ownership statement
Actionable Insight • Neutral
This filing confirms Sanofi's existing stake but provides no new trading catalyst. Monitor for any collaboration or additional investment announcements between Sanofi and Attovia.
Latest settled — T+20d ⚠ clustered
ATTO ▲ +5.62% at T+20d
NEUTRAL call +5.62% · α vs SPY +6.22% · entry $21.90 → $23.13
T+1d
-6.94%
call -6.94% · α -6.78%
$20.38
settled 3mo ago
T+5d
-17.53%
call -17.53% · α -17.89%
$18.06
settled 3mo ago
T+20d
+5.62%
call +5.62% · α +6.22%
$23.13
settled 8w ago
T+60d
Pending
in 16h
Price Chart
Loading chart...
Executive Summary
Sanofi filed a Form 3 initial statement of beneficial ownership for Attovia Therapeutics (ATTO), disclosing ownership of 782,855 common shares and Series C Preferred Stock convertible into common at $1.375 per share. This is a routine disclosure of an existing stake with no new transaction, partnership, or material change reported.
Key Facts
- Sanofi reported beneficial ownership of 782,855 shares of ATTO common stock.
- Sanofi also holds Series C Preferred Stock convertible into common stock at $1.375 per share (initial conversion price).
- The preferred stock is convertible at holder's option and automatically converts upon a Qualified Public Offering or Mandatory Conversion Time.
- A Form 3 is an initial beneficial ownership disclosure; it does not reflect a new transaction.
Financial Impact
Not specified
Risk Factors
- No material risk identified; the filing is routine and non-eventful.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-333095 |
| Document: 0001193125-26-333095-index.html | 0001193125-26-333095 |
| Document: 0001193125-26-333095.txt | 0001193125-26-333095 |
19 reports for ATTO
86% Hit rate @ T+20 Went positive at some point 7 of 7 best @ T+20▲ +26.67%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 3/A | $16.21 | awaiting T+20 | — | $15.00 (−7.46%) |
Oct 8, 2026 18d ago | 3/A | $16.21 | awaiting T+20 | — | $15.00 (−7.46%) |
Sep 28, 2026 28d ago | Press Release | $18.16 | awaiting T+20 | — | $15.00 (−17.40%) |
Sep 2, 2026 7w ago | Press Release | $24.20 $17.14 | ▼ −29.17% | ▼ −28.06% | $15.00 (−38.02%) |
Aug 28, 2026 8w ago | 144 / CLUSTER | $21.40 $18.16 | ▼ −15.14% | ▼ −14.95% | $15.00 (−29.91%) |
Aug 13, 2026 10w ago | Insider Buy | $19.86 $24.52 | ▲ +23.46% | ▲ +25.46% | $15.00 (−24.47%) |
Aug 13, 2026 10w ago | Insider Cluster | $19.86 $24.52 | ▲ +23.46% | ▲ +25.46% | $15.00 (−24.47%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.65 $22.86 | ▲ +22.57% | ▲ +23.63% | $15.00 (−19.57%) |
Aug 7, 2026 11w ago | Insider Cluster | $19.84 $23.66 | ▲ +19.25% | ▲ +20.17% | $15.00 (−24.40%) |
Aug 7, 2026 11w ago | Insider Cluster | $20.17 $25.55 | ▲ +26.67% | ▲ +27.07% | $15.00 (−25.63%) |
Showing 10 of 19
US Market Status
Market Closed — Opens Wed (17h 26m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers